WO2005007171A1 - ミネラル吸収促進剤及びその用途 - Google Patents
ミネラル吸収促進剤及びその用途 Download PDFInfo
- Publication number
- WO2005007171A1 WO2005007171A1 PCT/JP2004/009809 JP2004009809W WO2005007171A1 WO 2005007171 A1 WO2005007171 A1 WO 2005007171A1 JP 2004009809 W JP2004009809 W JP 2004009809W WO 2005007171 A1 WO2005007171 A1 WO 2005007171A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mineral absorption
- mass
- mineral
- parts
- cyclic tetrasaccharide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Definitions
- the present invention relates to a novel mineral absorption enhancer and its use, and more particularly, to a non-reducing property in which four dalcoses are cyclically linked with each other through a bond of 1,3 and 1,1,6.
- a novel mineral absorption enhancer containing saccharide represented by darcopyranosyl (1 ⁇ hereinafter simply referred to as “cyclic tetrasaccharide”
- the present invention relates to a composition for promoting mineral absorption containing the mineral absorption promoter.
- Collapse loss of calcium, an important component from calcium-containing tissues such as bones and teeth, causes bone diseases such as osteoporosis, fractures, back pain, tooth diseases such as caries and periodontal disease, and kidney stones Circulatory diseases such as urinary system, hypertension, and ischemic heart disease, anemia, diabetes, or a decrease in homeostasis of the living body.
- oil-based vitamins and hormones such as vitamin D, calcitonin preparations, estrogen preparations, anabolic hormone preparations, and bisphosphonates are administered in addition to various mineral preparations. ing.
- this method is more effective than simply taking minerals, it is not always satisfactory when using oil-soluble vitamins and hormones because the administration schedule is complicated and there is a risk of side effects due to excessive administration. It is a situation that cannot be said to be a method of doing. Excessive intake of various mineral preparations Accordingly, adverse effects, such as causing hypermineralemia, have also been problematic.
- JP-A-7-67575, 2002-306093 and JP-A-6-205653 disclose mineral absorption enhancers containing xylo-oligosaccharides, mannooligosaccharides, or lactylose oligosaccharides as active ingredients.
- Japanese Patent Publication No. 8 describes a bone strengthening agent containing ratatosuitalose and chondroitin sulfate calcium.
- some of these substances cause the taste, aroma, texture, etc. of the foods and drinks to decrease, and their effects will not be obtained unless they are consumed in large quantities.
- Many food materials have problems such as not being recognized.
- the palatability of the food or drink itself may be reduced due to its unique bitterness or metallic taste.
- WO 02Z072594 discloses that cyclic tetrasaccharide and / or a saccharide derivative thereof or a composition containing these saccharides has a mineral absorption property. The fact that it has a facilitating effect, and that it is disclosed at all.
- the first object of the present invention is to provide a mineral absorption promoter which is safe even when ingested and has an excellent effect of promoting mineral absorption.
- a second object is to provide a composition for use.
- the inventors of the present invention have long studied a mineral absorption promoter containing a saccharide as an active ingredient for the purpose of solving the above problems. As a result, they have found that cyclic tetrasaccharides and / or saccharide derivatives thereof have a strong effect on the promotion of mineral absorption, and further have a calcium tissue strengthening action represented by a bone strengthening action.
- a mineral absorption enhancer and a composition for promoting mineral absorption containing the mineral absorption enhancer have been established, and the present invention has been completed.
- composition according to the present invention includes foods and drinks, cosmetics, quasi-drugs, pharmaceuticals, feeds, feeds, and pet foods, and is used as a raw material, an intermediate raw material, and a raw material used in the production thereof.
- Any product can be used as long as it is a product that is manufactured by modification or a product that is manufactured using the product.
- cyclic tetrasaccharide referred to in the present invention is disclosed in International Publication WO 01/090338 and International Publication WO 02/010361, Akira Itoda, etc., which have four gnorecose forces, one, one and three.
- the saccharide derivative of a cyclic tetrasaccharide in the present invention refers to a saccharide in which one or two or more glycosinole groups S1 or two or more are bonded to a cyclic tetrasaccharide.
- a cyclic tetrasaccharide and a cyclic tetrasaccharide molecule such as a sugar solution obtained by combining a polyisomaltosyldarco saccharide-forming enzyme and a polyisomaltosyltransferase and acting on starch.
- a saccharide in which one or two or more glucoses are bound to two or more ⁇ H groups can be given.
- cyclomaltodextrin glucanotransferase, j3-galactosidase, ⁇ -galactosidase, lysozyme can be added to these saccharides by, for example, the method disclosed in International Publication WO 02/010361 by the present inventors.
- One or more enzymes having a glycosyltransferring ability such as a monosaccharide, an oligosaccharide and / or a polysaccharide serving as a substrate of the enzyme may be used.
- Carbohydrates obtained by transferring one or more of glycosinole groups such as dalcopyranosinole group, _D_galactobilanosinole group, and D-chitosaminyl group, and further transferred to saccharide derivatives of these cyclic tetrasaccharides, H-D-gunolecopyranosinole group, j3-D-galactopyranosinole group and / or j3_D-chitosaminyl group and other glycosyl groups, and further D-darcopyranosyl group, / 3_D_galactobilanoshi
- the cyclic tetrasaccharide and Z or a saccharide derivative thereof used in the present invention may be those produced by a fermentation method, an enzymatic method, an organic synthesis method, etc., regardless of their origin or production method.
- it may contain carbohydrates other than the carbohydrate other than the carbohydrate derived from its production raw materials such as glucose, isomaltose, maltose, oligosaccharides, dextrin and the like, which coexist in the production process of the cyclic tetrasaccharide.
- the cyclic tetrasaccharide used in the present invention and / or a saccharide derivative thereof is obtained by partially purifying the reaction solution obtained by the above method as it is or by using an ion exchange resin or the like. Further, it may be purified to a high purity from which impurities have been removed, or may be a mixture of one or more of the individual components of a highly purified cyclic tetrasaccharide or a saccharide derivative thereof. It may be something.
- This cyclic tetrasaccharide and / or a saccharide derivative thereof can be prepared, for example, by converting ⁇ -Vase into a cyclic tetrasaccharide by ⁇ -isomaltocinol transferase disclosed in the specification of International Publication WO 01/090338.
- a cyclic tetrasaccharide is produced by directly combining ⁇ -isomaltosyldarco saccharide-forming enzyme and ⁇ -isomaltosyltransferase from starch, as disclosed in WO 02/010361. It can be produced by an enzymatic method using starch or a saccharide derived therefrom as a raw material.
- the saccharide derivative of the cyclic tetrasaccharide can be produced by, for example, a method disclosed by the present applicant in International Publication WO 02/072594. These production methods can be carried out industrially advantageously, since a cyclic tetrasaccharide or a saccharide derivative thereof can be produced efficiently and inexpensively using abundant and inexpensive starch as a raw material.
- the cyclic tetrasaccharide includes anhydrous amorphous, anhydrous crystal, 1-hydrated crystal and 5-hydrated crystal, and any of them can be used. Furthermore, anhydrous crystals and one of the cyclic tetrasaccharides are included. Water crystals and anhydrous amorphous materials have excellent dehydration ability.
- a hydrate containing an unsaturated compound when powdered and solidified, it is removed by adding the hydrate to the hydrate. It also acts as a liquid medicine and can be used advantageously for the production of high quality powders and solid products containing cyclic tetrasaccharide as an active ingredient.
- the mineral in the present invention refers to calcium, magnesium, phosphorus, iron, manganese, sodium, potassium, copper, molybdenum, zinc, manganese, cobalt, selenium, iodine, fluorine, and the like required in vivo. .
- the mineral conjugate to be contained in the mineral absorption enhancer referred to in the present invention together with cyclic tetrasaccharide and Z or a saccharide derivative thereof includes a compound of the above mineral in a form that can be absorbed by a living body, and a mineral that can be absorbed by a living body. It refers to natural products with a high content or processed products containing these minerals. Specifically, for example, calcium compounds such as calcium carbonate, calcium chloride, calcium citrate, calcium dalconate, calcium glycerate, calcium lactate, calcium orthophosphate, calcium hydroxide and calcium oxide And whey calcium, bitter, eggshell calcium, cow bone calcium, fish bone meal, coral powder, shells and their processed products.
- magnesium compound examples include magnesium compounds such as magnesium carbonate, magnesium chloride, magnesium sulfate, magnesium acetate, magnesium dalconate, magnesium glycerate, magnesium lactate, magnesium orthophosphate, magnesium hydroxide, and magnesium oxide.
- magnesium compounds such as magnesium carbonate, magnesium chloride, magnesium sulfate, magnesium acetate, magnesium dalconate, magnesium glycerate, magnesium lactate, magnesium orthophosphate, magnesium hydroxide, and magnesium oxide.
- seaweeds such as cocoa beans, almonds, soybeans, peanuts, bitter, rice bran, hijiki, kelp, etc., and their processed products containing high levels of magnesium and magnesium.
- Examples of the potassium compound include potassium orthophosphate, potassium citrate, potassium chloride, potassium carbonate, potassium dalconate, potassium glycerate, potassium lactate, and potassium hydroxide.
- Examples of the sodium compound include sodium orthophosphate, sodium citrate, and sodium chloride.
- iron compound ferrous citrate, ferrous carbonate, ammonium ferric citrate, Potassium bicarbonate ferrous dalconate, ferrous lactate, ferrous sulfate, ferrous fumarate, sodium iron phosphate (ferric diphosphate), ferric monophosphate (ferric pyrophosphate) Iron), sugar-containing iron oxide, elemental iron, and the like.
- Examples of the manganese compound include manganese carbonate and manganese sulfate.
- cobalt compound examples include cobalt salt, cobalt carbonate, and cobalt sulfate.
- Copper compounds include cupric carbonate, cupric citrate, cupric dalconate, cupric sulfate
- Examples of the zinc compound include zinc acetate, zinc chloride, zinc citrate, zinc dalconate, zinc lactate, zinc oxide, zinc carbonate, zinc sulfate and the like.
- Examples of the molybdenum compound include ammonium molybdate and potassium molybdate.
- Examples of the selenium compound include sodium selenite, sodium hydrogen selenite, sodium selenite and the like.
- Examples of the fluorine compound include potassium fluoride and sodium fluoride.
- Examples of the iodine compound include sodium iodide, sodium iodate, potassium iodide, potassium iodate and the like.
- phosphorus, iron, manganese, potassium, copper, molybdenum, iodine, and fluorine natural products or processed products containing high content thereof are not specifically exemplified, but they are, of course, minerals of the present invention. It can be advantageously blended with the absorption promoter as a mineral conjugate.
- One or more of these mineral compounds can be appropriately blended depending on the purpose of use of the mineral absorption promoter of the present invention. It is optional to combine more than one kind and / or to combine two or more kinds of different kinds of mineral compounds.
- the mineral absorption enhancer used in the mineral absorption enhancer of the present invention together with cyclic tetrasaccharide and Z or a saccharide derivative thereof has a mineral absorption enhancer itself and / or , Cyclic tetrasaccharide and Z or any of those having an action of enhancing the mineral absorption promoting action of these saccharide derivatives can be used.
- Oligosaccharides galatatooligosaccharides, fratatooligosaccharides, nigerooligosaccharides, xylo-oligosaccharides, agaro-oligosaccharides, chitooligosaccharides, beet oligosaccharides, and ⁇ -trehalose, ⁇ _darcosyl and ⁇ disclosed in JP-A-7-143876 and the like —Trehalose ⁇ ⁇ -maltosyl and beetle, sugars such as rehalose, carbohydrate derivatives of trehalose, ratatosucrose, sonorebitone, maltitol, ratatitol, xylitol, erythritonore, cyclic diflatatose, and other carbohydrates, vitamin D, and filoquinone Vitamin K such as menacionone, menaquinone, menadione, vitamins such as asconolevinic acid and
- polyphenols examples include flavones, flavonols, flavanones, flavanonols, anthocyanidins, flavanols, chalcones, aurons, etc., and their precursors, aglycones, glycosides, or the like. And methylated, ethylated, methoxylated, ethoxylated, sulfated, glycosylated, etc., of which derivatives may be used.One or more selected from these may be used in appropriate combination. Is also optional.
- hesperetin, hesperidin, enzyme-treated hesperidin, methylated hesperidin, naringenin, naringin, enzyme-treated naringin, quercetin, rutin, enzyme-treated rutin, eriodictin, eriodictyol, proanthocyanidin, catechin, epicatechin, epigallocatechin, tannin, And melamine tannin are particularly desirable because they effectively enhance the mineral absorption promoting action of the cyclic tetrasaccharide and / or its saccharide derivative.
- Minerals such as zinc and magnesium having a calcium absorption promoting action can also be used as a mineral absorption promoter of the present invention.
- the mineral absorption promoter of the present invention can be used for livestock such as sea lions, horses and pigs, poultry such as chickens and ducks, cultured fish and shellfish such as Thailand, flounder, hamachi, clams and hamadari, which can only be obtained from humans.
- livestock such as sea lions, horses and pigs, poultry such as chickens and ducks, cultured fish and shellfish such as Thailand, flounder, hamachi, clams and hamadari, which can only be obtained from humans.
- Fish, shellfish and other insects such as silkworms and honeybees, crustaceans raised as pets, mammals such as dogs and cats, birds, reptiles, amphibians, and fish and shellfish can be used.
- the mineral absorption promoter containing cyclic tetrasaccharide and Z or a saccharide derivative thereof as an active ingredient used in the present invention can be used as it is, or as necessary, with a bulking agent, an excipient, and a binder.
- Syrup, paste, mask kit, powder, crystal granules, spherical, short It can be optionally used by shaping into various shapes such as a rod, a plate, a cube, and a tablet.
- the mineral absorption promoter of the present invention containing a cyclic tetrasaccharide and / or a saccharide derivative thereof may be any of various substances having other tastes such as sourness, salty taste, astringency, umami taste, and bitterness. It is well-balanced, can reduce off-flavors and off-flavors, and has high acid resistance and heat resistance, so it is advantageous as a raw material for general foods and drinks, quasi-drugs, pharmaceuticals, feed, feed, etc.
- the mineral absorption enhancer of the present invention can be used in the same manner as those containing no mineral absorption enhancer, and in addition, these products have an effect of promoting mineral absorption and an effect of strengthening calcium tissues such as bones and teeth.
- bone diseases such as osteoporosis, bone fracture, and back pain
- tooth diseases such as caries and periodontal disease
- urinary diseases such as kidney stones
- cardiovascular diseases such as hypertension and ischemic heart disease, anemia
- It can be advantageously used as food and drink, quasi-drugs, pharmaceuticals, intermediate processed products and raw materials for the treatment and prevention of diabetes or a decrease in the homeostasis of the living body. It can also be used as a tissue enhancer, a taste and odor reducing agent.
- the mineral absorption promoter of the present invention can be similarly used for feed, feed, pet food, and the like of livestock, poultry, pets, and the like.
- the mineral absorption enhancer of the present invention includes, for example, seasonings, complex seasonings, various kinds of Japanese confectionery, Western confectionery, bread, ice confectionery, syrup, paste, processed vegetable foods, pickles, pickles, Meat products, seafood products, delicacies, prepared foods, dairy products, soft drinks, various premixes, instant foods, refrigerated foods, frozen foods, chilled foods, retort foods, dried foods, as well as baby foods, therapeutic foods, drinks It can be used for the production of various foods and beverages such as kai J, peptide foods and frozen foods.
- these foods and drinks are provided with a mineral absorption promoting ability and / or a bone strengthening ability, they can be advantageously used as a composition for promoting mineral absorption and for enhancing Z or bone.
- a mineral absorption enhancer containing cyclic tetrasaccharide and Z or a saccharide derivative thereof as an active ingredient can be used as feed for livestock, poultry, bees, silkworms, freshwater fish, saltwater fish, crustaceans, and other raised animals. , Feed, pet food, etc., to impart a mineral absorption promoting ability and / or a calcium tissue strengthening ability.
- the method for incorporating the mineral absorption enhancer of the present invention into a target composition is not particularly limited.
- the method may be used until the target composition is completed or in a finished product. Good.
- Examples of the method include known methods such as mixing, kneading, dissolving, melting, dispersing, suspending, emulsifying, penetrating, crystallizing, spraying, coating, adhering, spraying, coating (coating), injecting, crystallizing, and solidifying. are appropriately selected.
- the mineral absorption enhancer of the present invention comprises a cyclic tetrasaccharide as an active ingredient and / or a saccharide derivative thereof in a total of about 0.1% by mass in terms of anhydride (hereinafter, not particularly specified in the present specification). As long as “% by mass” is simply expressed as “%”), those containing 0.5% or more, more preferably 1.0% or more, are preferred.
- the mineral absorption enhancer of the present invention may be composed of only a cyclic tetrasaccharide and / or a saccharide derivative thereof as long as it can exert a mineral absorption promoting action and a Z or bone strengthening action.
- composition containing the mineral absorption enhancer of the present invention contains, as an active ingredient, a physiologically active substance containing an amino group in a molecule such as an amino acid, the reducing saccharide such as gnorecose is used.
- the mineral absorption promoter of the present invention may be obtained by adding a cyclic tetrasaccharide and / or a saccharide derivative thereof in total. Is preferably 98% or more, preferably 99% or more, more preferably 99.5% or more, or hydrogenates a reducing saccharide that coexists with a cyclic tetrasaccharide and / or a saccharide derivative thereof. Then, it is also possible to use one having reduced reducibility.
- the mineral absorption enhancer of the present invention includes, for example, sugars such as powdered candy, glucose, maltose, sucrose, isomerized sugar, honey, maple sugar, dihydrochalcone, stevioside, polyglycosyl stevioside, and rebaudioside.
- Glycyrrhizin L-aspartyl-L_ phenylalanine methyl ester
- saccharin glycine
- alanine acesulfame K
- sugars such as sucralose, sweeteners, etc.
- An appropriate amount may be used by mixing with a bulking agent such as dextrin, starch, lactose, etc. which may be used by mixing.
- the daily intake of the mineral absorption enhancer of the present invention may be any amount as long as the mineral absorption enhancer can exhibit a mineral absorption promoting action and a bone or bone strengthening action.
- the total amount of the cyclic tetrasaccharide and / or the saccharide derivative thereof, which is the active ingredient, per kg of body weight is about 0.1 Olg or more, preferably about 0.5 g or more in terms of anhydride. More preferably, about 1. Og or more is suitable. Normally, if it is less than 0.1 Olg, it is insufficient to effectively exert the effect of promoting mineral absorption.
- the required number of times of intake of the mineral absorption enhancer of the present invention per day is the number of times that the mineral absorption enhancer can ingest an amount of a cyclic tetrasaccharide and / or a saccharide derivative thereof capable of exerting a mineral absorption promoting action.
- the mineral absorption enhancer of the present invention depending on the constitution, may be hungry when a large amount is taken at a time, so it is usually desirable to take the medicine in several divided doses. It should be used as a raw material for meals, or taken before and after a meal.
- the mineral absorption enhancer of the present invention is usually used as it is or when it is not possible to take it orally as a composition of foods and drinks, pharmaceuticals, quasi-drugs, etc. Injection directly into the stomach or intestinal tract using a catheter is optional.
- cyclic tetrasaccharides are It is known to have a fiber function. Dietary fiber is known to inhibit the absorption of minerals and enhance the excretion of minerals into feces (for example,
- each rat was dissected under ether anesthesia, the digestive tract is removed, and the jejunum, ileum, cecum, colon and rectum are removed.
- the weight of each organ in the intestine and the content of each organ were measured for the content weight, the amount of cyclic tetrasaccharide, the amount of minerals, and the amount of chromium.
- the cervical vertebra was dislocated from the rat from which the gastrointestinal tract was removed, the right femur was removed and its ash content, calcium content, magnesium content, and phosphorus content were measured.
- the method for quantifying cyclic tetrasaccharides and the method for measuring minerals and chromium are shown below.
- Feed lg 5 ml of 80% ethanol heated to 85 ° C is cultivated, refluxed for 15 minutes to extract carbohydrates, derivatized with TMS according to a conventional method, and gas chromatography equipment (GC_16A, manufactured by Shimadzu Corporation) Attach a ⁇ V_17 packed column (2% Silicone OV-17 Chromosorb W / AW DMSC 80—100mesh, 3mm ID X 2m, SUS, manufactured by GL Science), charge 3 ⁇ l of sample, and adjust the column temperature.
- GC_16A gas chromatography equipment
- the temperature was raised to 320 ° C at 7.5 ° C / min, and the cyclic tetrasaccharide was quantified using nitrogen gas (35 ml / min) as a carrier.
- nitrogen gas 35 ml / min
- 0.05 g of the contents was precisely weighed in a micro tube for gas chromatography and left in a desiccator containing phosphorus pentoxide to dry. Thereafter, in the same manner as in the case of feed, TMS derivatization was performed according to a conventional method, and quantification was performed using a gas chromatography apparatus.
- the residual ratio of cyclic tetrasaccharide (%) is based on the assumption that chromium is not absorbed at all in the living body, assuming that the ratio of cyclic tetrasaccharide to the amount of chromium in feed and the ratio of cyclic tetrasaccharide to the amount of chromium in each content or feces Based on the ratio of the amounts, the calculation formula: ⁇ (Amount of cyclic tetrasaccharide in each content or feces / Amount of chromium in each content or feces) / (Amount of cyclic tetrasaccharide in feed / Amount in feed Chromium amount) ⁇ X100.
- Table 4 shows the measurement results of the amounts of minerals and chromium in the feed.
- Table 5 shows the measurement results of calcium, magnesium, and chromium contents in the contents of the ileum, cecum, colon, and rectum, and feces
- Table 6 shows the measurement results of the iron and phosphorus contents. Each is shown. Also, based on these results, the accumulation of ileal contents, cecal contents, and minerals in feces The residual rate was calculated, and the integrated absorption rate up to each digestive tract was calculated. The results are shown in Tables 5 and 6.
- the absorption rate (%) of minerals is based on the assumption that chromium is not absorbed by living organisms at all, and the ratio of the amount of minerals to the amount of chromium in the feed and the amount of minerals to the amount of chromium in each content or feces Formula based on the ratio of the amount of minerals: 100- ⁇ [(the amount of minerals in each content or feces / the amount of chromium in each content or feces) Z (the amount of minerals in feed) Amount of chromium in cyclic tetrasaccharide in feed Z)] X 100 ⁇ .
- Table 7 shows the measurement results of the dry weight, ash content, calcium content, magnesium content, and phosphorus content of the femur.
- Cyclic tetrasaccharide is converted to anhydrous trihydrate 6.02 * 1.30 * 0.070 and then combined into 13 ⁇ 4 feed (79) (80)
- Ash content 0.63 0.64 * 0.65 g 0.66 * (g / g ⁇ dry femur)
- cyclic tetrasaccharide has the effect of promoting the absorption of calcium, magnesium, phosphorus and iron in the ileum or the digestive tract below it, depending on the amount of intake, and furthermore, the dryness of bone, It was confirmed to have the effect of increasing weight, ash content, minerals content, bone density, and strengthening bone.
- the effect of promoting mineral absorption when ingesting cyclic tetrasaccharides is observed in the ileum, cyclic tetrasaccharides are scarcely assimilated in the ileum. It was suggested that the mechanism of the promotion of absorption was different from the colonic fermentation reported for maltitol and ratatosucrose-flatatoligosaccharide.
- the digestive tract was divided into jejunum, ileum, colon and rectum, and the contents were washed with physiological saline. Cut out approximately 10 cm of the central part of each of the jejunum, ileum, colon and rectum, invert each intestinal tract using a glass rod, and place it in a saline solution publishing with a gas containing 95% oxygen and 5% carbon dioxide. Dipped. The inverted intestinal tract was cut every 5 cm, the both ends were tied with a suture, and an inverted intestinal sac was prepared. Using a syringe, 30 mM Tris-HCl buffer (pH 7.4), 125 mM was placed in the sac.
- inverted sac prepared from jejunum, ileum, and colon 'rectum contains cyclic tetrasaccharide and maltitol.
- the absorption of calcium was promoted depending on the concentration in both cases, as compared to the case containing no saccharide and the immersion in the sac external solution.
- cyclic tetrasaccharides strongly promoted absorption of calcium in the jejunum and ileum, and in the colon 'rectum, absorption was slightly enhanced with the addition of 200 mM, whereas multi-tonore increased absorption in the ileum and colon' ileum. Strongly promoted calcium absorption.
- composition containing a cyclic tetrasaccharide can be used for promoting mineral absorption in a living body and / or for enhancing bone.
- Example 1 to 8 Specific examples of the mineral absorption enhancer containing the cyclic tetrasaccharide of the present invention and Z or a saccharide derivative thereof as an active ingredient are described in Examples 1 to 8 below.
- the composition containing the accelerator is described in Example 9 to Example 29 with specific examples. However, the present invention is not limited by these examples.
- Example 2 from potato starch, a concentration of 80%, glucose 0.6% per solid, glucose isomaltose 1.5%, maltose 12.3%, cyclic tetrasaccharide 63.5%, cyclic tetrasaccharide saccharide derivative with one or more darcos linked to one or more darcos 5.2% and other carbohydrates 16.9%
- a syrup-like mineral absorption enhancer was prepared.
- the product can be used as it is as a mineral absorption enhancer and / or a bone enhancer, or by incorporating it into raw materials such as edible materials, pharmaceutical materials, feed materials, or intermediate products. It can be advantageously used for the preparation of compositions such as foods and drinks for promoting mineral absorption, quasi-drugs, pharmaceuticals, feeds and feeds.
- Example 9 According to the method disclosed in Example 9 disclosed in the specification of International Publication WO 01/090338 (without treatment with darcosidase and darcoamylase), a concentration of 73% from corn starch per solid was obtained. , Glucose 4.1%, disaccharides such as maltose and isomaltose 8.1%, trisaccharides such as maltotriose 4.6%, cyclic tetrasaccharide 35.2%, and one or two A syrup-like mineral absorption enhancer containing 15.6% of a saccharide derivative of a cyclic tetrasaccharide linked to glucose and 32.4% of another saccharide was prepared.
- This product can be used as it is, or it can be added to raw materials such as edible materials, pharmaceutical materials, feed materials, or intermediate products, or to promote mineral absorption and Z or bone reinforcement. of It can be advantageously used for the preparation of compositions for foods and drinks, quasi-drugs, pharmaceuticals, feeds, feeds, etc.
- Example 4 a syrup containing cyclic tetrasaccharide prepared from corn starch as a raw material was prepared according to the method described in International Publication WO 01/090338. Purification, concentration, and drying-crystallization were performed according to the methods described in 6 and Example 7 to obtain a powdery mineral absorption promoter composed of a cyclic tetrasaccharide pentahydrate crystal having a purity of 99.6%.
- This product can be used as it is, or by incorporating it into raw materials such as edible materials, pharmaceutical materials, feed materials, or intermediate products, etc., to promote food and drink for promoting mineral absorption and / or bone strengthening. It can be advantageously used for the preparation of quasi-drugs, pharmaceuticals, feeds, feeds and other compositions.
- the pentahydrate cyclic tetrasaccharide crystal is further dried according to the method of Experimental Example 31 or Experimental Example 32 disclosed in International Patent Publication WO 01/090338, to obtain a cyclic tetrasaccharide 1 hydrous crystal powder, or ,
- a mineral absorption promoter comprising anhydrous crystalline tetrasaccharide powder was prepared. All of these can be used as they are, or by incorporating them into raw materials such as edible materials, pharmaceutical materials, and feed materials, or intermediate products, to promote mineral absorption and / or strengthen bones. It can be advantageously used for the preparation of foods and drinks, quasi-drugs, pharmaceuticals, feeds, feeds and other compositions.
- Example 3 To 60 parts by mass of the hydrated crystal of the cyclic tetrasaccharide obtained in Example 3, 40 parts by mass of a commercially available anhydrous crystalline multitole (trade name “Mabit”, sold by Hayashibara Shoji Co., Ltd.) was mixed to obtain a powdery mixture A neural absorption promoter was obtained.
- This product can be used as it is, or it can be added to raw materials such as edible materials, pharmaceutical materials, feed materials, etc., or intermediate products to promote mineral absorption and / or to strengthen bones. It can be advantageously used for the preparation of compositions such as foods and drinks, quasi-drugs, pharmaceuticals, feeds and feeds.
- Example 3 To 50 parts by mass of the hydrated crystal of cyclic tetrasaccharide obtained in Example 3 was mixed 50 parts by mass of commercially available Hi, Hi-trehalose (trade name “Treha”, sold by Hayashibara Shoji Co., Ltd.) to obtain a powdered mineral. Sucking A yield promoter was obtained.
- Hi, Hi-trehalose trade name “Treha”, sold by Hayashibara Shoji Co., Ltd.
- This product can be used as it is, or by incorporating it into raw materials such as edible materials, medicinal materials, feed materials, or intermediate products, or foods for promoting mineral absorption and / or bone strengthening. It can be advantageously used for preparing quasi-drugs, pharmaceuticals, feeds, feeds and other compositions. In addition, the product can be easily granulated or added into tablets or granules or tablets by adding sugar ester or the like directly.
- Hi-trehalose (trade name “Treha”, sold by Hayashibara Shoji Co., Ltd.) are dissolved in water and concentrated under reduced pressure while heating to 60 ° C to give a trehalose concentration of 75%. Was prepared, and allowed to stand at room temperature to precipitate crystals. The procedure of washing the crystals with water was repeated twice, and then dried and pulverized to prepare a 99.8% pure water-containing crystal.
- -50 parts by mass of trehalose powder and 50 parts by mass of the pentahydrated cyclic tetrasaccharide obtained in Example 3 were homogeneously mixed to obtain a powdered mineral absorption promoter.
- This product can be used as it is, or by incorporating it into raw materials such as edible materials, pharmaceutical materials, feed materials, or intermediate products, or as a food or drink for promoting mineral absorption and / or strengthening bones. It can be advantageously used for the preparation of compositions such as quasi-drugs, pharmaceuticals, feeds and feeds. Since this product is composed of a highly pure cyclic tetrasaccharide and ⁇ , ⁇ -trehalose, it has extremely low reactivity and is stable. It can be suitably used for a composition that causes a reaction and deteriorates its quality. In addition, the product can be easily granulated by directly adding a sugar ester or the like, and further tableted, and can be easily used in the form of granules or tablets.
- Example 8 2 parts by mass of ascorbic acid 2-darcoside (sold by Hayashibara Biochemical Laboratories, Inc.) and 2 parts by mass of enzyme-treated hesperidin (Toyo Seikagyo Co., Ltd.) with respect to 70 parts by mass of the hydrated crystalline tetrasaccharide obtained in Example 3 And a trade name “aG hesperidin”) were mixed to obtain a powder mixture.
- This product can be used as it is, or by incorporating it into raw materials such as edible materials, medicinal materials, and feed materials, or intermediate products, to promote mineral absorption and / or to strengthen bones. It can be advantageously used for the preparation of compositions such as foods and drinks, quasi-drugs, pharmaceuticals, feeds and feeds.
- Powdered mineral absorption promoter consisting of pentahydrated crystals of cyclic tetrasaccharide prepared by the method of Example 3, 50 parts by mass of maltitol, 46 parts by mass of anhydrous crystalline maltitol, hesperidin transglycosylated (Toyo Seika Co., Ltd. Name “Hi G Hesperidin”) 3 parts by mass, sucralose (San-Ei Gen F 'F' I Co., Ltd.) 1 part by mass is dissolved in 200 parts by mass of water and spray dried by a conventional method to promote mineral absorption Was prepared. Since this product contains cyclic tetrasaccharide and transglycosyltransferred hesperidin, it can promote the absorption of minerals taken from other foods and drinks.
- a powdery mineral absorption promoter consisting of one hydrous crystal of the cyclic tetrasaccharide prepared in Example 3, 5 parts by weight of anhydrous crystalline maltitol powder (available from Hayashibara Shoji Co., Ltd., trademark “Mavit”) 94.5 parts by weight, L Aspartyl-L-phenylalanine methyl ester (available from Ajinomoto Co., Inc., trade name: “Aspartame”) After homogeneously mixing 0.5 parts by mass, granulate by a conventional method, and granulate sweetness to promote mineral absorption. A preparation was prepared.
- cyclic tetrasaccharides promote the absorption of minerals ingested as other foods and drinks from the intestinal tract, so that people with a diet deficient in minerals, bone strengthening, osteoporosis and metabolism It is suitable as a sweetener for preventing or treating diseases such as abnormalities and lifestyle-related diseases caused by a lack of minerals.
- the product is also suitable as a sweetener for pharmaceuticals and the like.
- Example 5 After mixing 100 parts by mass of soybean salad oil and 1 part by mass of lecithin with 10 parts by mass of water at room temperature, 100 parts by mass of the powdery mineral absorption enhancer prepared in Example 5 was mixed with the mixture, powdered, and sieved. A powdered fat for promoting mineral absorption was obtained. Since this product contains cyclic tetrasaccharides, ingestion of foods and drinks, feeds, and feeds prepared using this product will promote the absorption of minerals ingested as other foods and drinks from the intestinal tract. To supplement or supplement minerals to prevent or treat diseases such as osteoporosis and metabolic abnormalities such as lifestyle-related diseases such as osteoporosis and metabolic disorders, which are caused by lack of minerals. It is suitable as a raw material for animal feed, feed, pet food, and the like that need to be used.
- a commercially available beer preparation kit (Tokyu Nodes mail order club sales, product name "NB Beer Basic Set”) was purchased and prepared by the method of Example 1 for 100 parts by mass of the fermentation solution. 2 parts by mass of a syrup-like mineral absorption promoter were added and mixed, and beer was prepared according to the attached manual. Drinking this product promotes the absorption of minerals ingested from other foods and drinks. Furthermore, as a feed, feed, or pet food for animals that need to be supplemented with minerals for prevention or treatment of diseases such as osteoporosis and metabolic disorders, such as lifestyle-related diseases caused by a lack of minerals, or as a pet food, Can be advantageously used as a raw material. In addition, this product had a reduced unpleasant taste and Z or unpleasant odor peculiar to beer, and was sharp and delicious.
- This product was a delicious carrot extract powder in which the edible taste of the carrot extract was reduced.
- this product cyclic tetrasaccharides and royal jelly promote the absorption of minerals ingested from other foods and drinks, so that people with a diet deficient in minerals, bone strengthening, osteoporosis and metabolic abnormalities
- diseases such as lifestyle-related diseases caused by a lack of minerals, as feed, feed, pet food for animals that need to supplement minerals, as it is, or as a raw material for processing It can be used advantageously.
- this product was a powdered royal jelly that was easy to eat with reduced odor peculiar to royal jelly.
- cyclic tetrasaccharides promote the absorption of minerals taken from this product or other foods and drinks, so that people with a diet deficient in minerals, bone strengthening, and bone roughening It can be advantageously used for prevention or treatment of diseases such as lifestyle-related diseases caused by lack of minerals such as porosis and metabolic disorders.
- This product was a delicious chocolate with reduced characteristic stuffy odor caused by 2,3-butanedione and the like generated when chocolate was heated.
- Raspberry Puree 200 parts by weight, granulated sugar 46 parts by weight, syrupy mineral absorption accelerator 12 parts prepared by the method of Example 2, starch syrup 50 parts by weight, alpha, alpha _ Trueno, loin (Hayashibara Shoji, 122 parts by mass, 5 parts by mass of pectin, 3 parts by mass of a 50% aqueous solution of citric acid, 27 parts by mass of isomerized sugar, and an appropriate amount of water. The mixture was slowly boiled down, poured into an appropriate mold, and cooled at room temperature to prepare a hard jelly for promoting mineral absorption.
- This product is a product of cyclic tetrasaccharides and their carbohydrate derivatives that promote the absorption of minerals ingested from other foods and drinks.
- ⁇ C for promoting mineral absorption 60 parts by mass of sugar, 20 parts by mass of ⁇ , ⁇ -trehalose (trade name “Treha” sold by Hayashibara Corporation), 35 parts by mass of a syrup-like mineral absorption promoter prepared by the method of Example 1, and an amino acid mixture 1 Then, 5 parts by mass and 85 parts by mass of water were added, and a hard candy for promoting mineral absorption was produced by a conventional method.
- cyclic tetrasaccharides and their carbohydrate derivatives promote the absorption of minerals ingested from other foods and drinks.
- humans with a diet deficient in minerals, bone strengthening, and osteoporosis It can be used advantageously for prevention or treatment of diseases such as lifestyle-related diseases caused by mineral deficiency such as metabolism and metabolic disorders.
- Bread rice flour pre-mixed with dartene 400 parts by mass, salt 8 parts by mass, cyclic tetrasaccharide 5 hydrous crystal prepared in Example 3
- a vertical mineral powder containing 40 parts by weight of a powdery mineral absorption promoter, 12 parts by weight of white sucrose, 12 parts by weight of skim milk powder, 1 part by weight of raw yeast, 8 parts by weight of punorelane, and 320 parts by weight of water. After stirring and mixing with a mixer, 20 parts by mass of butter was added to further prepare a kneaded dough.
- Example 4 To a liquid prepared by mixing 375 parts by weight of water and 13.5 parts by weight of the powdered mineral absorption enhancer prepared in Example 4, add 300 parts by weight of washed and drained rice for 1 hour After immersion, the rice was cooked as it was in a domestic rice cooker to obtain cooked rice for promoting mineral absorption.
- This product contains cyclic tetrasaccharides, so eating this cooked rice will result in this product or other food or drink. It promotes the absorption of minerals ingested from other sources, such as humans who have a diet deficient in minerals, bone strengthening, and lifestyle-related diseases caused by mineral deficiencies such as osteoporosis and metabolic disorders. It can be advantageously used as a feed, feed or pet food for animals that need to supplement minerals for prevention or treatment of diseases, as it is, or as a raw material for processing. This product was delicious cooked rice with reduced rice bran odor.
- the frozen pickpocket was thawed after freezing at _20 ° C for 90 days, and thawed at 150 parts by mass of ice water, 40 parts by mass of sodium gnoretamate, 100 parts by mass of potato starch, 3 parts by mass of sodium polyphosphate, 50 parts by mass of sodium chloride and 100 parts by mass of an aqueous solution in which 5 parts by mass of sorbitol had been dissolved was added, and the mixture was mashed, and about 120 g each was fixed and attached to a plate. These were steamed so that the temperature of the inside became about 80 ° C in 30 minutes.
- This product promotes the absorption of minerals in cyclic tetrasaccharides and proanthocyanidins.It is used for diet, to prevent lifestyle-related diseases, or to limit fat intake, obesity and hyperlipidemia. It is suitable as food for patients with lifestyle-related diseases or as a material thereof. This product was a delicious kneaded product with reduced odor due to oxidation and decomposition of lipids.
- this mixture was dissolved in 92 parts by mass of water to prepare a gel mineral drink.
- the product promotes the absorption of minerals that have been ingested, such as cyclic tetrasaccharide and ratatosucrose power or other foods and drinks, and can be advantageously used for efficient replenishment of minerals and water during sports. .
- this product since this product is in a gel form, it is also suitable as a hydration and mineral supplement for the sick, elderly and children who have difficulty in swallowing, as it is less likely to accidentally enter the trachea like water.
- the product is a savory beverage with improved palatability because the bitterness of the mineral itself is reduced and the aftertaste of sugar / sucralose is also improved.
- a syrup-like mineral absorption enhancer prepared by the method of Example 2 144 parts by mass of a syrup-like mineral absorption enhancer prepared by the method of Example 2 and 202 parts by mass of a commercially available bittern (manufactured by Sanuki Salt Industry Co., Ltd.) are mixed and completely dissolved while heating to 70 ° C. The solution was concentrated under reduced pressure to obtain a solution having a solid concentration of 63%. In this product, the bitterness of the mineral itself is reduced, and the cyclic tetrasaccharide promotes the absorption of minerals taken by force such as this product or other foods and drinks.
- a raw material for sports drinks health foods, foods for the elderly and the sick, and fortified with coagulants and other foods and drinks, cosmetics, pharmaceuticals, etc. It can optionally be used as a raw material for quasi-drugs, pharmaceuticals, feed, and feed.
- This product has reduced chemical odor peculiar to vitamin, and the cyclic tetrasaccharide promotes the absorption of minerals taken from this product or other foods and drinks.
- this product has reduced unpleasant tastes and / or unpleasant odors such as medicinal odor peculiar to vitamins even after long-term storage, and suppresses oxidation and decomposition of vitamins, which absorb moisture, and is easy to take. Les, vitamins.
- Example 3 75 parts by weight of precipitated calcium carbonate, 3 parts by weight of ferrous fumarate, 12 parts by weight of magnesium carbonate, 3 parts by weight of tocopherol acetate, 5 parts by weight of ascorbic acid, and the cyclic tetrasaccharide 5 hydrous crystal prepared by the method of Example 3 200 parts by mass of the mineral absorption promoter contained and 1 part by mass of sugar ester were homogeneously mixed and tableted by a conventional method to prepare a tablet of 250 mg per tablet. This product has reduced bitterness exhibited by the mineral itself, and the cyclic tetrasaccharide promotes the absorption of minerals taken from this product or other foods and drinks, and strengthens calcium tissue.
- a mineral agent was prepared by uniformly mixing 5 parts by mass of darcoside, 1 part by mass of glycosyltransferred rutin, and 200 parts by mass of a mineral absorption enhancer containing the hydrated crystalline tetrasaccharide prepared by the method of Example 3. This product has reduced bitterness, metallic taste, metallic odor and other off-flavors and odors exhibited by minerals such as calcium, iron, and magnesium.
- This product is used for animals that require mineral supplementation because cyclic tetrasaccharides, their carbohydrate derivatives and glycosylated rutin promote the absorption of minerals taken from this product or other foods and drinks. It is suitable as feed for livestock, poultry, poultry, pets, etc., and is particularly suitable as feed for piglets.
- the present invention effectively uses cyclic tetrasaccharide and Z or a saccharide derivative thereof, which are non-reducing saccharides containing gnorecose, which can be used for promoting mineral absorption in animals including humans.
- the present invention relates to a mineral absorption enhancer contained as a component and a composition for promoting mineral absorption containing the mineral absorption enhancer. Since the cyclic tetrasaccharide and / or its carbohydrate derivative is safe and very stable even when taken orally, the cyclic tetrasaccharide according to the present invention and / or its sugar derivative is very stable.
- the fields of application of mineral absorption enhancers containing carbohydrate derivatives as active ingredients cover a wide variety of fields, such as the food and beverage field, cosmetics field, quasi-drugs, and pharmaceuticals.
- the present invention is an invention having such remarkable functions and effects, and its industrial contribution is a significant invention.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Nutrition Science (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020067000970A KR101110983B1 (ko) | 2003-07-18 | 2004-07-09 | 미네랄 흡수 촉진제 및 그 용도 |
US10/565,069 US20060210646A1 (en) | 2003-07-18 | 2004-07-09 | Accelerator for mineral absorption and use thereof |
EP04747277A EP1652527A4 (en) | 2003-07-18 | 2004-07-09 | MINERAL ABSORBENT AND ITS USE |
JP2005511818A JP4702745B2 (ja) | 2003-07-18 | 2004-07-09 | ミネラル吸収促進剤及びその用途 |
US11/961,899 US7994155B2 (en) | 2003-07-18 | 2007-12-20 | Accelerator for mineral absorption and use thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003-276602 | 2003-07-18 | ||
JP2003276602 | 2003-07-18 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/565,069 A-371-Of-International US20060210646A1 (en) | 2003-07-18 | 2004-07-09 | Accelerator for mineral absorption and use thereof |
US11/961,899 Division US7994155B2 (en) | 2003-07-18 | 2007-12-20 | Accelerator for mineral absorption and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005007171A1 true WO2005007171A1 (ja) | 2005-01-27 |
Family
ID=34074596
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/009809 WO2005007171A1 (ja) | 2003-07-18 | 2004-07-09 | ミネラル吸収促進剤及びその用途 |
Country Status (6)
Country | Link |
---|---|
US (2) | US20060210646A1 (ja) |
EP (1) | EP1652527A4 (ja) |
JP (1) | JP4702745B2 (ja) |
KR (1) | KR101110983B1 (ja) |
TW (1) | TW200503640A (ja) |
WO (1) | WO2005007171A1 (ja) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006306845A (ja) * | 2005-03-28 | 2006-11-09 | Taisho Pharmaceut Co Ltd | 銅化合物配合組成物 |
US20090023684A1 (en) * | 2005-04-20 | 2009-01-22 | Hitomi Ohta | Fluid for peritoneal dialysis |
JP2010095474A (ja) * | 2008-10-17 | 2010-04-30 | Ito En Ltd | カルシウム吸収促進組成物及びカルシウム吸収促進飲食物 |
JP2013528224A (ja) * | 2010-06-09 | 2013-07-08 | エミスフェアー・テクノロジーズ・インク | 経口鉄欠乏療法 |
JP2015140347A (ja) * | 2014-01-30 | 2015-08-03 | 明治飼糧株式会社 | 家畜の暑熱ストレス軽減剤 |
JP2018509176A (ja) * | 2015-01-26 | 2018-04-05 | カデナ・バイオ・インコーポレイテッド | 動物飼料として使用するためのオリゴ糖組成物及びその生成方法 |
KR20190053527A (ko) * | 2017-11-10 | 2019-05-20 | 김양희 | 다이어트 기능을 지닌 반려동물 사료의 제조를 위한 혼합조성물 |
WO2021066159A1 (ja) | 2019-10-04 | 2021-04-08 | 株式会社林原 | 環状四糖を含有する糖組成物とその用途並びに製造方法 |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060280694A1 (en) * | 2005-06-09 | 2006-12-14 | John Peldyak | Composition for the mineralization of dental hard tissues and the reduction of caries-inducive microflora |
EP1932530A4 (en) * | 2005-08-11 | 2009-04-29 | Hayashibara Biochem Lab | MEANS FOR IMPROVING COLLAGEN PRODUCTION AND ITS USE |
EP1937286B1 (en) | 2005-09-12 | 2016-03-09 | Abela Pharmaceuticals, Inc. | Compositions comprising dimethyl sulfoxide (dmso) |
EP1966229B1 (en) | 2005-09-12 | 2015-10-21 | Abela Pharmaceuticals, Inc. | Systems for removing dimethyl sulfoxide (dmso) or related compounds, or odors associated with same |
US8480797B2 (en) | 2005-09-12 | 2013-07-09 | Abela Pharmaceuticals, Inc. | Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors |
US8435224B2 (en) | 2005-09-12 | 2013-05-07 | Abela Pharmaceuticals, Inc. | Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds |
JP5781727B2 (ja) * | 2007-02-23 | 2015-09-24 | 株式会社ネクスト21 | 血管攣縮の治療剤又は予防剤 |
JP2009291151A (ja) * | 2008-06-06 | 2009-12-17 | Dainichiseika Color & Chem Mfg Co Ltd | 家畜又は伴侶動物用の飼料組成物及び飲用水 |
BRPI0921494A2 (pt) | 2008-11-03 | 2018-10-30 | Prad Reasearch And Development Ltd | método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração. |
MX353712B (es) | 2009-10-30 | 2018-01-24 | Abela Pharmaceuticals Inc | Formulaciones de sulfoxido de dimetilo (dmso) y metilsulfonilmetano (msm) para tratar osteoartritis. |
BE1019709A3 (fr) * | 2010-12-22 | 2012-10-02 | Calxx Laboratoires S A | Produit alimentaire organo-mineral et procede de preparation. |
US9433583B2 (en) | 2011-04-22 | 2016-09-06 | Frank J. Farrell | Colon vitamin |
CN105725092A (zh) * | 2016-02-26 | 2016-07-06 | 江凯 | 改善肉制品品质的组合物 |
WO2018045122A1 (en) * | 2016-09-02 | 2018-03-08 | Tate & Lyle Ingredients Americas Llc | Use of tri-and tetra-saccharides as taste modulators |
CN107348130A (zh) * | 2017-07-25 | 2017-11-17 | 安徽皖山食品有限公司 | 一种富硒抗氧化颗粒饲料的制备方法 |
CN109480112A (zh) * | 2018-12-29 | 2019-03-19 | 广州傲农生物科技有限公司 | 一种复合饲料添加剂及其制备方法与应用 |
CN115553385A (zh) * | 2021-07-02 | 2023-01-03 | 广州市正百生物科技有限公司 | 提高动物抗应激能力及免疫力的饲料添加剂、制备方法及饲料 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06205653A (ja) * | 1993-01-08 | 1994-07-26 | Snow Brand Milk Prod Co Ltd | ラクチュロースオリゴ糖を有効成分とするミネラル吸収促進剤 |
JPH0767575A (ja) * | 1993-08-31 | 1995-03-14 | Suntory Ltd | ミネラル吸収促進組成物 |
WO2002057011A1 (fr) * | 2001-01-19 | 2002-07-25 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Agent deshydratant et procede de deshydratation d'un article humide a l'aide dudit agent et article deshydrate ainsi obtenu |
JP2002255988A (ja) * | 2001-03-05 | 2002-09-11 | Hayashibara Biochem Lab Inc | 糖質混合物とその製造方法並びに用途 |
JP2002306093A (ja) * | 2001-04-17 | 2002-10-22 | Ajinomoto General Foods Inc | マンノオリゴ糖を含有するミネラル吸収促進組成物 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3188583B2 (ja) | 1993-02-25 | 2001-07-16 | 明治製菓株式会社 | マグネシウム補給材とその利用 |
JP3693359B2 (ja) | 1993-07-21 | 2005-09-07 | マルハ株式会社 | 骨強化促進剤 |
US7192746B2 (en) * | 2000-05-22 | 2007-03-20 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | α-Isomaltosyltransferase, process for producing the same and use thereof |
TWI312369B (en) | 2000-08-01 | 2009-07-21 | Hayashibara Biochem Lab | A-isomaltosylglucosaccharide synthase,process for producing the same and use thereof |
US7223570B2 (en) * | 2001-03-09 | 2007-05-29 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Branched cyclic tetrasaccharide, process for producing the same, and use |
JP2003160595A (ja) * | 2001-11-20 | 2003-06-03 | Hayashibara Biochem Lab Inc | 糖誘導体 |
JP4397142B2 (ja) * | 2001-11-20 | 2010-01-13 | 株式会社林原生物化学研究所 | 活性酸素消去能低減抑制剤 |
JP4181829B2 (ja) * | 2001-11-22 | 2008-11-19 | 株式会社林原生物化学研究所 | 香気の保持方法並びにその用途 |
JP4893981B2 (ja) * | 2003-04-03 | 2012-03-07 | 株式会社林原生物化学研究所 | 脂質調節剤及びその用途 |
-
2004
- 2004-07-09 EP EP04747277A patent/EP1652527A4/en not_active Ceased
- 2004-07-09 WO PCT/JP2004/009809 patent/WO2005007171A1/ja active Application Filing
- 2004-07-09 US US10/565,069 patent/US20060210646A1/en not_active Abandoned
- 2004-07-09 KR KR1020067000970A patent/KR101110983B1/ko active IP Right Grant
- 2004-07-09 JP JP2005511818A patent/JP4702745B2/ja not_active Expired - Fee Related
- 2004-07-14 TW TW093121011A patent/TW200503640A/zh not_active IP Right Cessation
-
2007
- 2007-12-20 US US11/961,899 patent/US7994155B2/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06205653A (ja) * | 1993-01-08 | 1994-07-26 | Snow Brand Milk Prod Co Ltd | ラクチュロースオリゴ糖を有効成分とするミネラル吸収促進剤 |
JPH0767575A (ja) * | 1993-08-31 | 1995-03-14 | Suntory Ltd | ミネラル吸収促進組成物 |
WO2002057011A1 (fr) * | 2001-01-19 | 2002-07-25 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Agent deshydratant et procede de deshydratation d'un article humide a l'aide dudit agent et article deshydrate ainsi obtenu |
JP2002255988A (ja) * | 2001-03-05 | 2002-09-11 | Hayashibara Biochem Lab Inc | 糖質混合物とその製造方法並びに用途 |
JP2002306093A (ja) * | 2001-04-17 | 2002-10-22 | Ajinomoto General Foods Inc | マンノオリゴ糖を含有するミネラル吸収促進組成物 |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006306845A (ja) * | 2005-03-28 | 2006-11-09 | Taisho Pharmaceut Co Ltd | 銅化合物配合組成物 |
US20090023684A1 (en) * | 2005-04-20 | 2009-01-22 | Hitomi Ohta | Fluid for peritoneal dialysis |
US9066968B2 (en) | 2005-04-20 | 2015-06-30 | Hayashibara Co. Ltd | Fluid for peritoneal dialysis |
JP2010095474A (ja) * | 2008-10-17 | 2010-04-30 | Ito En Ltd | カルシウム吸収促進組成物及びカルシウム吸収促進飲食物 |
JP2013528224A (ja) * | 2010-06-09 | 2013-07-08 | エミスフェアー・テクノロジーズ・インク | 経口鉄欠乏療法 |
JP2015140347A (ja) * | 2014-01-30 | 2015-08-03 | 明治飼糧株式会社 | 家畜の暑熱ストレス軽減剤 |
JP2018509176A (ja) * | 2015-01-26 | 2018-04-05 | カデナ・バイオ・インコーポレイテッド | 動物飼料として使用するためのオリゴ糖組成物及びその生成方法 |
KR20190053527A (ko) * | 2017-11-10 | 2019-05-20 | 김양희 | 다이어트 기능을 지닌 반려동물 사료의 제조를 위한 혼합조성물 |
KR102176515B1 (ko) * | 2017-11-10 | 2020-11-09 | 김양희 | 다이어트 기능을 지닌 반려동물 사료의 제조 방법 |
WO2021066159A1 (ja) | 2019-10-04 | 2021-04-08 | 株式会社林原 | 環状四糖を含有する糖組成物とその用途並びに製造方法 |
Also Published As
Publication number | Publication date |
---|---|
KR20060052818A (ko) | 2006-05-19 |
US20080113938A1 (en) | 2008-05-15 |
EP1652527A1 (en) | 2006-05-03 |
TW200503640A (en) | 2005-02-01 |
TWI340631B (ja) | 2011-04-21 |
US7994155B2 (en) | 2011-08-09 |
JP4702745B2 (ja) | 2011-06-15 |
EP1652527A4 (en) | 2012-03-14 |
US20060210646A1 (en) | 2006-09-21 |
KR101110983B1 (ko) | 2012-03-13 |
JPWO2005007171A1 (ja) | 2007-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4702745B2 (ja) | ミネラル吸収促進剤及びその用途 | |
JP5270144B2 (ja) | マルトビオン酸、その塩又はマルトビオノデルタラクトン含有組成物の用途 | |
JP2779963B2 (ja) | ビフィズス菌増殖促進剤 | |
JP6581902B2 (ja) | エネルギー消費の促進および/またはエネルギー消費機能低下の治療および/または予防剤、または方法 | |
JP5876205B2 (ja) | D−ソルボースからなる甘味料におけるd−ソルボースの甘味の不足や、甘味の持続を改良する方法 | |
US8940715B2 (en) | Lipid-regulating agent and use thereof | |
JP2010521420A (ja) | 健康増進剤製造のための、ベタインおよび/またはコリンと組み合わせたグアニジノ酢酸(塩)の使用 | |
KR101721145B1 (ko) | L-카르니틴 구연산 마그네슘을 포함하는 배변촉진 겸용 다이어트용 식품 조성물 | |
JPH0937711A (ja) | 健康食品 | |
JP5586713B2 (ja) | ミネラル可溶化安定剤 | |
JP3552075B2 (ja) | 易吸収性カルシウム組成物 | |
JP4746281B2 (ja) | 生体内脂質調節剤 | |
JP5628355B2 (ja) | ミネラル吸収促進剤及び易吸収性カルシウム剤 | |
JP5695098B2 (ja) | 脂質代謝改善剤 | |
KR101306931B1 (ko) | 골다공증 예방 효과를 가지는 유기태화 칼슘 강화 유단백질 | |
JP4493736B2 (ja) | キチンを含有するミネラル吸収促進性組成物およびミネラル吸収促進用添加剤 | |
JP7359415B2 (ja) | ウレアーゼ阻害剤 | |
JP2004016119A (ja) | ダイオキシン類排泄促進用組成物 | |
JP2006342061A (ja) | ミネラル含有水溶液組成物 | |
JPH11243914A (ja) | カルシウム吸収促進飲食物 | |
KR0144566B1 (ko) | 비피드균 증식 촉진제 | |
JP5943516B2 (ja) | D−ソルボースを有効成分とする生体機能改善用甘味料 | |
JP2000333643A (ja) | 高分子量キチンまたはキトサンを含有するミネラル吸収促進性組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005511818 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020067000970 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10565069 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004747277 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004747277 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020067000970 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 10565069 Country of ref document: US |